santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

Platelet Activating Factor (PAF) Receptor Agonists and Antagonists

  • 1-O-Hexadecyl-2-acetyl-sn-glycero-3-phospho-(N,N,N-trimethyl)-hexanolamine
    PAF antagonist. Shows inhibitory behavior on platelet aggregation, secretion and phospholipid turnover.
    Katalog #CAS NummerSummenformelMenge
    sc-20286299103-16-9C30H62NO7P5 mg/25 mg
  • Araguspongin B
    Products isolated from Pacific basin sponges with notable vasodilatory properties. Serve as important signal transduction messengers acting to promote transfer of Ca2+ from intracellular stores. Shown to exhibit an antagonizing effect of the calcium-releasing action of inosital 1,4,5-triphosphate at receptor levels in cerebral microsomes.
    Katalog #CAS NummerSummenformelMenge
    sc-205215123000-02-2C28H50N2O2100 µg/250 µg
  • Bis(methylthio)gliotoxin (FR-49175)
    Analog of gliotoxin shown to inhibit PAF-induced platelet aggregation and speed up PAF hydrolysis.
    Katalog #CAS NummerSummenformelMenge
    sc-20102774149-38-5C15H20N2O4S21 mg/5 mg
  • C-PAF (Carbamyl-PAF )
    C-PAF (Carbamyl-PAF) is utilized as a non-hydrolyzable bioactive analog of PAF.
    Katalog #CAS NummerSummenformelMenge
    sc-20102591575-58-5C26H55N2O7P5 mg/25 mg
  • (±) cis-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane
    Inactive enantiomer of (±) trans-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane, a PAFr inhibitor. Useful as a negative control.
    Katalog #CAS NummerSummenformelMenge
    sc-201031116673-47-3C21H26O81 mg/5 mg
  • CV-3988
    A specific antagonist of PAF binding to the PAF receptor. Inhibits PAF-induced platelet aggregation.
    Katalog #CAS NummerSummenformelMenge
    sc-20101585703-73-7C28H53N2O7PS5 mg/25 mg
  • Eptifibatide
    A selective inhibitor of platelet glycoprotein IIb/IIIa receptors.
    Katalog #CAS NummerSummenformelMenge
    sc-205675148031-34-9C35H49N11O9S25 mg/10 mg
  • ET-18-OCH3
    An ether lipid analogue that induces selective apoptosis in tumor cells without affecting normal cells. Agent has ability activate intracellular Fas/CD95 and inhibit activation of p70S6K.
    Katalog #CAS NummerSummenformelMenge
    sc-20102177286-66-9C27H58NO6P5 mg/25 mg
  • Ginkgolide B (BN 52021)
    Most potent member of ginkgolide family of PAF antagonists. Has been found to accelerate PAF hydrolysis by promoting PAF-AH I α2 homodimer activity.
    Katalog #CAS NummerSummenformelMenge
    sc-20103715291-77-7C20H24O1010 mg/50 mg
  • PCA 4248
    A dihydropyridine that inhibits PAF in a competitive manner at the PAF receptor level. Shown to also reduce serotonin secretion caused by PAF.
    Katalog #CAS NummerSummenformelMenge
    sc-203446123875-01-4C19H23NO4S10 mg/50 mg
  • Octylonium Bromide
    Reported to antagonize platelet-activating factor induced aggregation of rabbit platelet-rich plasma. Demonstrates the ability to potently block neuronal nicotinic acetylcholine receptors.
    Katalog #CAS NummerSummenformelMenge
    sc-20103526095-59-0C29H43N2O4Br5 mg/25 mg
  • (±) trans-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane
    (±) trans-2,5-Bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane is a selective and potent platelet activating factor (PAF) antagonist of the diaryl tetrahydrofuran class. Reported to block LTP in field CA1 in rat hippocamp
    Katalog #CAS NummerSummenformelMenge
    sc-201029116673-45-1C21H26O81 mg/5 mg
  • WEB-2086
    WEB-2086 (Apafant) is a Platelet Activating Factor (PAF) receptor antagonist shown to have anticancer and cell differentiation effects.
    Katalog #CAS NummerSummenformelMenge
    sc-201007105219-56-5C22H22ClN5O2S1 mg/5 mg